Showing results (181-190 of 211) with videos related to
Sort By:
Pageof 22
Psychoneuroendocrinology|October 25, 2003
Serum melatonin and urinary 6-sulfatoxymelatonin in major depressionM Crasson, S Kjiri, A Colin, et al.Psychoneuroendocrinology|January 1, 1988
Inhibitory influence of oxytocin infusion on contingent negative variation and some memory tasks in normal menV Geenen, F Adam, V Baro, et al.International Clinical Psychopharmacology|August 5, 1998
A double-blind comparison of the efficacy and safety of milnacipran and fluoxetine in depressed inpatientsJ D Guelfi, M Ansseau, E Corruble, et al.Psychoneuroendocrinology|November 1, 1992
Apomorphine stimulation of vasopressin- and oxytocin-neurophysins. Evidence for increased oxytocinergic and decreased vasopressinergic function in schizophrenicsJ J Legros, C Gazzotti, T Carvelli, et al.Psychoneuroendocrinology|January 1, 1985
Diagnostic performance of the thirty-four hour dexamethasone suppression testM Ansseau, A Doumont, J L Cerfontaine, et al.Psychiatry Research|November 1, 1984
Use of saliva cortisol in the dexamethasone suppression testM Ansseau, J Sulon, A Doumont, et al.Psychoneuroendocrinology|January 1, 1987
Intranasal oxytocin in obsessive-compulsive disorderM Ansseau, J J Legros, C Mormont, et al.Journal of Affective Disorders|December 16, 2003
High prevalence of mental disorders in primary careM Ansseau, M Dierick, F Buntinkx, et al.Journal of Clinical Psychopharmacology|December 1, 1985
Extrapyramidal signs following zimelidine overdoseM Ansseau, C F Reynolds, D J Kupfer, et al.The Journal of Clinical Psychiatry|June 1, 1986
Central dopaminergic and noradrenergic receptor blockade in a patient with neuroleptic malignant syndromeM Ansseau, C F Reynolds, D J Kupfer, et al.Pageof 22